MASON HEYWOOD: Open Payments
NPI 1902391857 · TOOELE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $29 |
| Lilly USA, LLC | 1 | $24 |
| Medtronic, Inc. | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, MAVYRET, TRINTELLIX, Ozempic, ZEPBOUND, MINIMED 780G, Vest Therapy Und, Cologuard Collection Kit.
Industry payments across UT — which companies pay providers there.
